CN EN

Contact Auscon Biotech

  • Service Consultation

    Early research and biopharmaceutical sector business:

    86-0513-68067603

  • Product consultation

    Cell culture media business

    400-004-6572

  • Group marketing and media cooperation consultation

    178 2653 0418

  • Group personnel recruitment consulting

    86-0513-88067602

  • Nantong

    Aosikang Biotechnology (Nantong) Joint Stock Co., Ltd.

    Address: Building B1, No. 100 Dongtinghu Road, Linjiang Town, Haimen District, Nantong City, Jiangsu Province (Headquarters)

  • Nantong

    JSBio Biotechnology (Nantong) Co., Ltd.

    Address:No. 3 Hailin Road, Linjiang Town, Haimen District, Nantong City, Jiangsu Province, China

  • Shanghai

    Shanghai Aosikang Biopharmaceutical Co., Ltd

    Address: Building 5, No. 1215 Zhengjia Road, Lingang New Area, China (Shanghai) Pilot Free Trade Zone, Shanghai, China

  • Shanghai

    Shanghai Ginspire Biotechnology Co., Ltd

    Address: Rooms 402, 206-207, No. 1043 Halle Road, China (Shanghai) Pilot Free Trade Zone, Shanghai, China

  • Gansu

    Gansu JSBio Biosciences Co., Ltd.

    Address: No. 70 Jiuzhou Tongxi Road, Anning District, Lanzhou City, Gansu Province, China

Production Base

Nantong Macromolecular Drug Industrialization Base
The Nantong Macromolecular Drug Industrialization Base specializes in the commercial production of antibodies, proteins, and macromolecular drugs. The base is equipped with five traditional bulk production lines (200L/500L/2000L disposable bioreactors) and one perfusion process production line, as well as vial injection/lyophilization and prefilled syringe formulation production lines, with a single batch capacity of 100,000 bottles and 64,000 vials respectively.
Nantong Macromolecular Drug Industrialization Base
The Nantong Macromolecular Drug Industrialization Base specializes in the commercial production of antibodies, proteins, and macromolecular drugs. The base is equipped with five traditional bulk production lines (200L/500L/2000L disposable bioreactors) and one perfusion process production line, as well as vial injection/lyophilization and prefilled syringe formulation production lines, with a single batch capacity of 100,000 bottles and 64,000 vials respectively.

I Want to Contact Aosikang Biotech

Products of interest

Submit